Impact of gut microbiome dysbiosis on prostate cancer
DOI:
https://doi.org/10.52340/healthecosoc.2025.09.01.03Keywords:
probiotics, diet, short chain fatty acids, metabolic pathways, prostate cancer, gut microbiome dysbiosisAbstract
Introduction: The gut microbiome is integral for regulating metabolism, immune functions, and inflammation, with growing evidence suggesting its involvement in the growth and course of prostate cancer (PCa). This review examines the effect of gut microbiome alterations in influencing PCa incidence and risk, factors leading to prostate cancer development, advancement, and resistance to treatment. Methodology: A comprehensive literature review was conducted, analysing peer-reviewed studies on the effects of gut microbiome dysbiosis on prostate cancer. Results: Distinct microbial patterns such as a rise in pro-inflammatory Bacteroides massiliensis and a decrease in anti-inflammatory Faecalibacterium prausnitzii seen in PCa patients which can be used as a biomarker for making a diagnosis of prostate cancer from other prostate-related conditions. Also, the production of bile acids and short-chain fatty acids by gut bacteria can interfere with hormone synthesis, and a diet high in fat and reduced fiber can lead to dysbiosis eventually causing PCa. Conclusion: The study underscores the relevance of gut microbiome dysbiosis and its relation to androgen regulation, inflammatory reactions, and metabolic pathways—all of which have a role in the development of prostate cancer. A good dietary approach and probiotics together with traditional methods like androgen restriction therapy can lead to well-balanced outcomes in patients.
References
Baptissart, M., Vega, A., Martinot, E., Baron, S., Lobaccaro, J. M., & Volle, D. H. (2013). Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling? Cellular and molecular life sciences: CMLS, 70(23), 4511–4526. https://pmc.ncbi.nlm.nih.gov/articles/PMC11113643/
Fujita, K., Matsushita, M., Banno, E., De Velasco, M. A., Hatano, K., Nonomura, N., & Uemura, H. (2022). Gut microbiome and prostate cancer. International Journal of Urology, 29(8), 793–798. https://doi.org/10.1111/iju.14894
Fujita, K., Matsushita, M., De, M. A., Hatano, K., Minami, T., Norio Nonomura, & Uemura, H. (2023). The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome. Cancers, 15(5), 1375–1375. https://doi.org/10.3390/cancers15051375
Golombos, D. M., Ayangbesan, A., O’Malley, P., Lewicki, P., Barlow, L., Barbieri, C. E., … Scherr, D. S. (2018). The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study. Urology, 111, 122–128. https://doi.org/10.1016/j.urology.2017.08.039
Kim, S. J., Park, M., Choi, A., & Yoo, S. (2024). Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities. Pharmaceuticals (Basel, Switzerland), 17(1), 112. https://doi.org/10.3390/ph17010112
Kustrimovic, N., Bombelli, R., Baci, D., & Mortara, L. (2023). Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment. International Journal of Molecular Sciences, 24(2), 1511. https://doi.org/10.3390/ijms24021511
Liss, M. A., White, J. R., Goros, M., Gelfond, J., Leach, R., Johnson-Pais, T., … Shah, D. P. (2018). Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer. European Urology, 74(5), 575–582. https://pmc.ncbi.nlm.nih.gov/articles/PMC6716160/
Matsushita, M., Fujita, K., Hatano, K., De, M. A., Tsujimura, A., Uemura, H., & Norio Nonomura. (2023). Emerging Relationship between the Gut Microbiome and Prostate Cancer. The World Journal of Men’s Health, 41(4), 759–759. https://doi.org/10.5534/wjmh.220202
Matsushita, M., Fujita, K., Motooka, D., Hatano, K., Fukae, S., Kawamura, N., … Nonomura, N. (2021). The gut microbiota associated with high‐Gleason prostate cancer. Cancer Science, 112(8), 3125–3135. https://pmc.ncbi.nlm.nih.gov/articles/PMC8353908/
Munteanu, R., Feder, R.-I., Anca Onaciu, Munteanu, V. C., Iuga, C., & Gulei, D. (2023). Insights into the Human Microbiome and Its Connections with Prostate Cancer. Cancers, 15(9), 2539–2539. https://doi.org/10.3390/cancers15092539
Sfanos, K. S., Markowski, M. C., Peiffer, L. B., Ernst, S. E., White, J. R., Pienta, K. J., … Ross, A. E. (2018). Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer and Prostatic Diseases, 21(4), 539–548. https://doi.org/10.1038/s41391-018-0061-x
Yang, H. J., & Kim, J. H. (2023). Role of microbiome and its metabolite, short chain fatty acid in prostate cancer. Investigative and Clinical Urology, 64(1), 3. https://doi.org/10.4111/icu.20220370
